Pediatric Endocrinologist, researching the early stages of type 1 diabetes, father of three
Joined April 2009
- Tweets 307
- Following 856
- Followers 137
- Likes 940
6 Photos and videos
Markus Lundgren retweeted
20 Oct 2022
LUDC researchers Helena Elding Larsson and Markus Lundgren @Markus76 have contributed with data from the #POInT study in Sweden to this new article @jclinicalinvest: jci.org/articles/view/162123
#type1diabetes #T1D #GPPAD @HelmholtzMunich @helmholtz_diabc @AWorldWithout_1 @medfak_LU
17 Oct 2022
#Type1diabetes: When and why does it manifest in children? Results of the #POInT study published @jclinicalinvest provide novel insights on dynamics of blood sugar levels and autoimmunity in early childhood #T1D #GPPAD #AnetteGabrieleZiegler👉t1p.de/1l2n0
2
2
Markus Lundgren retweeted
14 Nov 2023
It’s #WorldDiabetesDay2023! Meet some of our #GPPAD superheroes 🦸🏽‍♀️🦸🏼‍♂️🦸🏻
1
2
5
289
Markus Lundgren retweeted
20 Sep 2023
Professor Suzanne Bennett Johnson from Florida State University College of Medicine will present research about the relationship between physical activity and the development of #type1diabetes on our CRC seminar in Malmö on September 26, 12.00-13.00. ludc.lu.se/calendar/crc-semi…
1
4
282
Markus Lundgren retweeted
8 Sep 2023
In this study, in young children with high genetic risk of type 1 diabetes, #SARSCoV2 infection was temporally associated with the development of islet autoantibodies. ja.ma/3qXtCVr
9
23
12,663
8 Sep 2023
Glad to have been part of this work. Excellent lead by Ezio Bonifacio`s @tudresden_de team in the GPPAD study group. #GPPAD #T1D #LUDC
8 Sep 2023
In this study, in young children with high genetic risk of type 1 diabetes, #SARSCoV2 infection was temporally associated with the development of islet autoantibodies. ja.ma/3qXtCVr
2
143
Markus Lundgren retweeted
1 Mar 2023
Enrollment in the IMPACT study has been completed!👏Congratulations to IMCYSE! 🎉 This trial, in collaboration within INNODIA, investigates an immunotherapy, called Imotopes™, that has the potential to stop the progression of #type1diabetes
Read more: ➡ lnkd.in/eVfMKRAd
6
11
1,072
Markus Lundgren retweeted
2 Dec 2022
How often do you hear misconceptions about your #Type1Diabetes? Do people try and tell you what you should and shouldn't eat without any knowledge of your condition, and how you manage it? Find out how you can help those who aren't in the know about #T1D: jdrf.org.uk/information-supp…
2
32
83
Markus Lundgren retweeted
17 Oct 2022
#Type1diabetes: When and why does it manifest in children? Results of the #POInT study published @jclinicalinvest provide novel insights on dynamics of blood sugar levels and autoimmunity in early childhood #T1D #GPPAD #AnetteGabrieleZiegler👉t1p.de/1l2n0
2
12
35
Markus Lundgren retweeted
23 Aug 2022
Blood testing in children leads to better understanding of #type1diabetes #T1D. This improved understanding makes it possible to conduct new types of studies with the goal of preventing the disease. Find out more: lunduniversity.lu.se/article…
@medfak_LU @lunduniversity @Markus76
ALT Children taking part in the TEDDY study in Sweden have an increased risk of developing type 1 diabetes and are screened for the disease. Research nurse Jessica Melin takes a blood sample from one of the participants. Photograph: Kennet Ruona
2
2
Markus Lundgren retweeted
7 Jul 2022
I'm delighted that my recent publication with the fantastic T1DI collaborators got published @ the diabetes leading journal with an impact factor of 44.8.
@HagopianWilliam
@RVeijola
@IBMResearch
@JDRF
@jianying_hu
@vibhamath
@TheLancetEndo
@jessdunnephd
New—Two-age islet-autoantibody screening for #childhood type 1 #diabetes: a prospective cohort study thelancet.com/journals/landi… #T1D
3
7
6 Jul 2022
So glad to see this paper come to fruition. Especially great work by @mohamed08163706 and @HagopianWilliam! #T1DI #DiPiS #ludc
New—Two-age islet-autoantibody screening for #childhood type 1 #diabetes: a prospective cohort study thelancet.com/journals/landi… #T1D
10
Markus Lundgren retweeted
6 Jul 2022
Really proud to have led the effort with #T1DI to use existing data to uncover underlying questions in #T1D. In our latest paper, we used the data to determine the optimal ages to screen with the goal to use this approach as an entry into public health screening for T1D.
New—Two-age islet-autoantibody screening for #childhood type 1 #diabetes: a prospective cohort study thelancet.com/journals/landi… #T1D
6
12
52
Markus Lundgren retweeted
13 May 2022
@BCKwon, @vibhamath, @jessdunnephd, @jianying_hu, @markus76, @RVeijola, @brigittef, @IBMResearch, @JDRF, @medfak_LU leverage longitudinal clinical and autoantibody data to model and visualize the progression to diabetes nature.com/articles/s41467-0…
7
20
Markus Lundgren retweeted
22 Mar 2022
A study published in @NatureComms has identified three distinct pathways towards #type1diabetes in children. Researchers at LUDC have contributed with data from a prospective study in Sweden: ludc.lu.se/article/large-int…
@IBMResearch @JDRFResearch @medfak_LU @lunduniversity @Markus76
1
7
12
Markus Lundgren retweeted
14 Apr 2021
Berzelius Symposium 103 – Immunity and autoimmunity in early childhood will be postponed until next year. New dates are June 2-3, 2022, in Stockholm! Keep an eye out for updates! #immunity
1
2
Markus Lundgren retweeted
19 Mar 2021
This study will be one of the exciting studies conducted at our research unit in Malmö. Preliminary study start with recruitment of infants will be this spring!
19 Mar 2021
New clinical study SINT1A aims to prevent #type1diabetes.
The study explores the potential of a specific #probiotic to strengthen the #ImmuneSystem early-on in children with increased genetic risk of type 1 diabetes.
‣ bit.ly/3tF63fs
#aworldwithout1 #GPPAD
1
2